Pharmaceuticals occupiers in Dublin typically cluster in CBD / St Stephen's Green, plan ~220 sqft per seat at high-end fit-out ($150–220/sqft), and pay around 65 EUR/sqft ($78 USD) on Class A.
Pharmaceuticals occupiers in Dublin typically cluster in CBD / St Stephen's Green, plan ~220 sqft per seat at high-end fit-out">fit-out ($150–220/sqft), and pay around 65 EUR/sqft ($78 USD) on Class A.
Pharmaceuticals occupiers in Dublin typically anchor in CBD / St Stephen's Green. Banking, law, professional services, government, consulting.
Class A rent in Dublin runs 65 EUR/sqft ($78 USD) on a 10-year lease with 12 months free. Prime submarkets sit at or modestly above the city index.
Typical pharmaceuticals fit-out targets high-end specification at $150–220/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 220 sqft per seat blended (workstation + circulation + amenity). A 100-headcount pharma office in Dublin typically targets 22,000 sqft of leasable area.
Commercial and medical-affairs teams cluster near academic-medical anchors; large floor plates support cross-functional brand teams. Deep tech, pharma, finance, and legal services talent. EU talent pool accessible without immigration friction. Strong feed from TCD, UCD, and the broader Irish university system.
Headline corporate tax: 12.5%. FRI (Full Repairing and Insuring) leases dominate. 10-year terms with tenant break options at year 5 standard. Free rent of 9-15 months and TI of €60-€110/sqm typical.
| city | Dublin |
|---|---|
| industry | Pharmaceuticals |
| naics | 3254, 5417 |
| preferredSubmarket | CBD / St Stephen's Green |
| preferredFitoutSpec | High-end |
| fitoutBand | $150–220/sqft |
| sqftPerSeat | 220 |
| classARentLocal | 65 EUR/sqft/yr |
| classARentUsd | $78/sqft/yr |
| vacancyPct | 14.3% |
| typicalLeaseYears | 10 |
| typicalRentFreeMonths | 12 |
| talentIndex | 86 |
| corporateTaxPct | 12.5% |
Reviewed by Samuel Okafor — EMEA contributing editor. Last updated 2026-04-15. See our methodology and editorial standards.